What is the brand name of pramipexole?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Brand Name of Pramipexole

The brand name of pramipexole is Mirapex (or Mirapex ER for the extended-release formulation). 1

Brand Name Details

Pramipexole was first manufactured by Pharmacia and Upjohn in July 1997 under the United States brand names Mirapex and Mirapex ER 1. The drug is also marketed under the brand name Sifrol in some international markets, particularly by Boehringer Ingelheim 2.

Generic Availability

Generic pramipexole dihydrochloride tablets are now widely available and have been shown to be bioequivalent to the brand-name formulations 2, 3. Studies demonstrate that generic pramipexole has:

  • Comparable efficacy to brand-name formulations in treating Parkinson's disease
  • Similar safety profiles with no significant difference in adverse event occurrence
  • Significantly lower cost while maintaining therapeutic equivalence 3

Clinical Context

Pramipexole is classified as a nonergoline aminobenzothiazole compound and dopamine D2-like receptor agonist with D3-preferring properties 1. It is FDA-approved for:

  • Treatment of signs and symptoms of idiopathic Parkinson's disease 4, 1
  • Moderate to severe symptoms of primary restless legs syndrome 5, 1

The medication is available in both immediate-release and extended-release formulations, with the extended-release version allowing for once-daily dosing 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.